Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.
作者信息
Bloch Michael J, Basile Jan N
出版信息
J Clin Hypertens (Greenwich). 2010 Sep;12(9):661-3. doi: 10.1111/j.1751-7176.2010.00369.x. Epub 2010 Aug 24.
Abstract
摘要
相似文献
1
Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.
J Clin Hypertens (Greenwich). 2010 Sep;12(9):661-3. doi: 10.1111/j.1751-7176.2010.00369.x. Epub 2010 Aug 24.
2
Critical review of cancer risk associated with angiotensin receptor blocker therapy.
Vasc Health Risk Manag. 2011;7:741-7. doi: 10.2147/VHRM.S13552. Epub 2011 Dec 12.
3
[Angiotensin II receptor blockers (ARBs) and cancer: a reassuring balance].
Rev Med Suisse. 2011 Sep 14;7(308):1757-8, 1760.
4
Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancer.
Eur Heart J. 2011 Jan;32(1):19-22. doi: 10.1093/eurheartj/ehq382. Epub 2010 Oct 21.
5
[Angiotensin receptor blockers and risk of cancer].
Anadolu Kardiyol Derg. 2011 Jun;11(4):374-5. doi: 10.5152/akd.2011.094. Epub 2011 May 18.
6
No connection between ARBs and cancer.
Harv Heart Lett. 2011 Aug;21(12):6.
7
Risk of cancer associated with the use of angiotensin II-receptor blockers.
Am J Health Syst Pharm. 2011 Nov 15;68(22):2139-46. doi: 10.2146/ajhp100570.
8
Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?
Curr Hypertens Rep. 2012 Jun;14(3):183-92. doi: 10.1007/s11906-012-0263-x.
9
[Angiotensin II antagonists and cancer: a storm that can do good ].
Rev Med Suisse. 2010 Sep 15;6(262):1691-2.
10
A review of clinical studies on angiotensin II receptor blockers and risk of cancer.
Int J Cardiol. 2014 Dec 20;177(3):748-53. doi: 10.1016/j.ijcard.2014.11.031. Epub 2014 Nov 6.
引用本文的文献
1
Angiotensin and systems thinking: wrapping your mind around the big picture.
Ochsner J. 2013 Spring;13(1):11-25.
本文引用的文献
1
Angiotensin-receptor blockers and cancer: urgent regulatory review needed.
Lancet Oncol. 2010 Jul;11(7):605-6. doi: 10.1016/S1470-2045(10)70142-X. Epub 2010 Jun 11.
2
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
Lancet Oncol. 2010 Jul;11(7):627-36. doi: 10.1016/S1470-2045(10)70106-6. Epub 2010 Jun 11.
3
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet. 2003 Sep 6;362(9386):759-66. doi: 10.1016/s0140-6736(03)14282-1.
Zotero 插件